Bio News
The U.S. Food and Drug Administration (FDA) has approved Implantica’s RefluxStop implant for the treatment of gastroesophageal reflux disease (GERD). The device is implanted in the upper stomach through laparoscopic surgery to prevent acid from rising into the esophagus. Implantica plans to establish logistics and distribution infrastructure in the United States and expand its organization.
BIOBOOK TEAM
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
